Open Access
CC BY-NC-ND 4.0 · Endosc Int Open 2024; 12(10): E1206-E1213
DOI: 10.1055/a-2341-9026
Original article

Colorectal tumor comorbidity is common in patients with duodenal tumors: Exploratory cross-sectional study

Authors

  • Mari Mizutani

    1   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
  • Motohiko Kato

    2   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine Graduate School of Medicine, Tokyo, Japan (Ringgold ID: RIN38084)
  • Kazuhiro Yamanoi

    3   Department of Pathology, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Akiko Matsubara

    4   Division of Diagnostic Pathology, Shiga University of Medical Science Hospital, Otsu, Japan (Ringgold ID: RIN469340)
  • Atsushi Nakayama

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Kayoko Fukuhara

    6   Center for Preventive Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Kentaro Iwata

    7   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Kurato Miyazaki

    7   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Teppei Masunaga

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Yoko Kubosawa

    7   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Yukie Hayashi

    8   Center for Preventive Medicine, Keio University School of Medicine Department of Internal Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN592818)
  • Yusaku Takatori

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Teppei Akimoto

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Noriko Matsuura

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Rieko Bessho

    6   Center for Preventive Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Tomohisa Sujino

    9   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Kaoru Takabayashi

    9   Center for Diagnostic and Therapeutic Endoscopy, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Hitoshi Ichikawa

    6   Center for Preventive Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Kazuhiro Kashiwagi

    6   Center for Preventive Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Hiromasa Takaishi

    6   Center for Preventive Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Yasunori Sato

    10   Department of Biostatistics, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Takanori Kanai

    7   Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
  • Ryoji Kushima

    4   Division of Diagnostic Pathology, Shiga University of Medical Science Hospital, Otsu, Japan (Ringgold ID: RIN469340)
  • Naohisa Yahagi

    5   Division of Research and Development for Minimally Invasive Treatment, Cancer Center, Keio University School of Medicine Graduate School of Medicine, Shinjuku-ku, Japan (Ringgold ID: RIN38084)
Clinical Trial: Registration number (trial ID): UMIN000038749, Trial registry: UMIN Japan (http://www.umin.ac.jp/english/), Type of Study: Exploratory cross-sectional study

Abstract

Background and study aims The duodenum and colorectum are target organs for familial colorectal adenomatous polyposis, however, the association of duodenal epithelial tumors (DETs) and colorectal tumors is still controversial. The aim of our study was to elucidate the association between DET and colorectal tumor.

Patients and methods This was an exploratory cross-sectional study of patients with DETs treated by endoscopic resection at our hospital, between November 2018 and October 2022. Individuals who underwent colonoscopy as part of the health screening comprised the reference control group for comparison. In both groups, lesions suspected of being tumors were resected. The main outcome was the adenoma detection rate (ADR). Other outcomes were the detection rate for advanced neoplasia (AN) and risk factors for colorectal adenoma and AN, evaluated using univariate and multivariable analyses.

Results Analyses were based on data from 163 individuals in the DET group and 177 in the control group. ADR was higher in the DET (63.2%) than in the control (23.6%) group (P < 0.001). AN and invasive cancer rates were also significantly higher in the DET than in the control group (AN: 20.9% vs 3.4%, respectively, P < 0.001; invasive cancer: 3.1% vs 0%, respectively, P < 0.001). On logistic regression analysis, DET was found to be associated with a 5-fold increase in the detection rate of adenoma and 6-fold increase in AN detection.

Conclusions The study revealed significant association between DET and high ADR and a higher frequency of AN and invasive cancer. Screening colonoscopy is suggested for patients with DETs.



Publication History

Received: 05 December 2023

Accepted after revision: 05 June 2024

Accepted Manuscript online:
10 June 2024

Article published online:
28 October 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany